Merit Medical Systems, Inc. (MMSI) vs PDS Biotechnology Corporation (PDSB)

A side-by-side comparison of Merit Medical Systems, Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 30, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnMMSI vs PDSB

growth of $100 · dividends reinvested · last 10y
MMSI +286.0% (+14.5%/yr)PDSB -99.9% (-49.0%/yr)MMSI compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$386$0
MMSI PDSB

MMSI vs PDSB: by the numbers

  • MMSI is the larger company ($5.40B vs $12M market cap).
  • MMSI is profitable (9.22% net margin) while PDSB runs a net loss (0.00%).

Metrics side by side

Valuation

MetricMMSIPDSB
P/E ratio37.39N/A
Forward P/E21.03N/A
P/S ratio3.44N/A
P/B ratio3.233.45
EV / EBITDA17.200.02
FCF yield3.75%N/A

Profitability

MetricMMSIPDSB
Gross margin49.52%0.00%
Operating margin12.75%0.00%
Net margin9.22%0.00%
ROE8.67%-372.85%
ROIC5.80%-3699.99%

Growth (annualized)

MetricMMSIPDSB
Revenue CAGR (5Y)8.90%N/A
EPS CAGR (5Y)67.27%N/A
FCF CAGR (5Y)8.96%N/A
Total return CAGR (5Y)4.77%-57.05%

Frequently asked

Is MMSI or PDSB more profitable?
MMSI runs the higher net margin — MMSI at 9.22% versus PDSB at 0.00%.
How have MMSI and PDSB total returns compared?
Over the past 10 years, MMSI delivered 14.40% and PDSB delivered -49.05% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 30, 2026.